New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Risk of internal bleeding doubles when people on anticoagulants take NSAID painkiller, study finds

Risk of internal bleeding doubles when people on anticoagulants take NSAID painkiller, study finds

byEuropean Society of CardiologyInteractions between non-steroidal anti-inflammatory drugs (NSAIDs) and oral anticoagulants (OACs) that may contribute to excess risk of gastrointestinal (GI) and
Cardiovascular Diseases November 29,2024
Risk of internal bleeding doubles when people on anticoagulants take NSAID painkiller, study finds

Risk of internal bleeding doubles when people on anticoagulants take NSAID painkiller, study finds

byEuropean Society of CardiologyInteractions between non-steroidal anti-inflammatory drugs (NSAIDs) and oral anticoagulants (OACs) that may contribute to excess risk of gastrointestinal (GI) and
Cardiovascular Diseases November 29,2024
Neuropathic pain drugs linked to higher hip fracture risk in seniors

Neuropathic pain drugs linked to higher hip fracture risk in seniors

by Teju Hari Krishna,Monash UniversityCredit: Pixabay/CC0 Public DomainA new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat neu
Orthopedics & Sports medicine November 29,2024
Neuropathic pain drugs linked to higher hip fracture risk in seniors

Neuropathic pain drugs linked to higher hip fracture risk in seniors

by Teju Hari Krishna,Monash UniversityCredit: Pixabay/CC0 Public DomainA new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat neu
Orthopedics & Sports medicine November 29,2024
More than half of U.S. adults could be candidates for Ozempic

More than half of U.S. adults could be candidates for Ozempic

by Ernie MundellMore than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds.Sold as Ozempic for treating&nbsp
Diabetes & Endocrinology November 29,2024
More than half of U.S. adults could be candidates for Ozempic

More than half of U.S. adults could be candidates for Ozempic

by Ernie MundellMore than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds.Sold as Ozempic for treating&nbsp
Diabetes & Endocrinology November 29,2024
Nasal spray version of common diuretic has potential to help treat heart failure

Nasal spray version of common diuretic has potential to help treat heart failure

byAmerican Heart AssociationCredit: Unsplash/CC0 Public DomainA new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as the sta
Cardiovascular Diseases November 29,2024
Nasal spray version of common diuretic has potential to help treat heart failure

Nasal spray version of common diuretic has potential to help treat heart failure

byAmerican Heart AssociationCredit: Unsplash/CC0 Public DomainA new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as the sta
Cardiovascular Diseases November 29,2024
Two-medication combo pill lowered blood pressure among adults in India

Two-medication combo pill lowered blood pressure among adults in India

byAmerican Heart AssociationCredit: Pavel Danilyuk from PexelsMedication variations that combined two of three different blood pressure-lowering medications into a single pill worked equally wel
Cardiovascular Diseases November 29,2024
Two-medication combo pill lowered blood pressure among adults in India

Two-medication combo pill lowered blood pressure among adults in India

byAmerican Heart AssociationCredit: Pavel Danilyuk from PexelsMedication variations that combined two of three different blood pressure-lowering medications into a single pill worked equally wel
Cardiovascular Diseases November 29,2024
'Staggeringly high' discontinuation rates for GLP-1 drugs like Ozempic or Wegovy

'Staggeringly high' discontinuation rates for GLP-1 drugs like Ozempic or Wegovy

by Kristin Samuelson,Northwestern UniversityCredit: Markus Winkler from PexelsThe use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent yea
Diabetes & Endocrinology November 29,2024
'Staggeringly high' discontinuation rates for GLP-1 drugs like Ozempic or Wegovy

'Staggeringly high' discontinuation rates for GLP-1 drugs like Ozempic or Wegovy

by Kristin Samuelson,Northwestern UniversityCredit: Markus Winkler from PexelsThe use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent yea
Diabetes & Endocrinology November 29,2024
European watchdog partially approves new Alzheimer's drug

European watchdog partially approves new Alzheimer's drug

Credit: Unsplash/CC0 Public DomainEurope's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier
Neurology November 29,2024
European watchdog partially approves new Alzheimer's drug

European watchdog partially approves new Alzheimer's drug

Credit: Unsplash/CC0 Public DomainEurope's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier
Neurology November 29,2024
Novel oral medication muvalaplin lowers Lp(a) in a small international trial

Novel oral medication muvalaplin lowers Lp(a) in a small international trial

byAmerican Heart AssociationCredit: Unsplash/CC0 Public DomainA clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a
Cardiovascular Diseases November 29,2024
Novel oral medication muvalaplin lowers Lp(a) in a small international trial

Novel oral medication muvalaplin lowers Lp(a) in a small international trial

byAmerican Heart AssociationCredit: Unsplash/CC0 Public DomainA clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a
Cardiovascular Diseases November 29,2024
Diabetes meds metformin and GLP-1s can also curb asthma, research finds

Diabetes meds metformin and GLP-1s can also curb asthma, research finds

by Ernie MundellDrugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British research shows.The two drugs aremetformin, one of the most
Pulmonology November 29,2024
Diabetes meds metformin and GLP-1s can also curb asthma, research finds

Diabetes meds metformin and GLP-1s can also curb asthma, research finds

by Ernie MundellDrugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British research shows.The two drugs aremetformin, one of the most
Pulmonology November 29,2024
Blood thinners fail to reduce cognitive decline in adults 65 and younger with AFib, research finds

Blood thinners fail to reduce cognitive decline in adults 65 and younger with AFib, research finds

byAmerican Heart AssociationLena Rivard M.D., M.Sc., electrophysiologist at Montreal Heart Institute and associate professor of medicine at Université de Montréal in Canada. Credit: Antoine Sato
Cardiovascular Diseases November 29,2024
Blood thinners fail to reduce cognitive decline in adults 65 and younger with AFib, research finds

Blood thinners fail to reduce cognitive decline in adults 65 and younger with AFib, research finds

byAmerican Heart AssociationLena Rivard M.D., M.Sc., electrophysiologist at Montreal Heart Institute and associate professor of medicine at Université de Montréal in Canada. Credit: Antoine Sato
Cardiovascular Diseases November 29,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com